Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Primary Myelofibrosis 1Polycythemia Vera 1Lymphoma, Follicular 1

Interventions

ruxolitinib 2umbralisib 1iadademstat 1fludarabine phosphate 1decitabine and cedazuridine drug combination 1Whole-Body Irradiation 1Tacrolimus 1Specimen Handling 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Etoposide 1Cyclosporine 1Cyclophosphamide 1Busulfan 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycythemia Vera × umbralisib × 30 days × Clear all
NCT02493530 2026-05-19

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

Vanderbilt-Ingram Cancer Center

Phase 1 Completed
60 enrolled
Myeloid

Polycythemia Vera, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡